Search for: "Abbott Laboratories, Inc."
Results 101 - 120
of 451
Sort by Relevance
|
Sort by Date
14 Aug 2014, 5:14 am
Deborah Malin worked in the IT department of the Abbott Laboratories’s hospital product division (spun off to a new company, Hospira, in 2006). [read post]
5 Aug 2014, 9:09 am
Studies Indicate Health Risks from Testosterone Therapy AndroGel is a topical testosterone-replacement medication produced and marketed by Abbott Laboratories and its AbbVie Inc. subsidiary. [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
16 Jul 2014, 10:03 am
AndroGel testosterone gel is a topical testosterone replacement therapy (TRT) manufactured by AbbVie, Inc. and formerly Unimed Pharmaceuticals of Abbott Laboratories, Inc. [read post]
12 Jun 2014, 8:48 pm
Several research institutions—including Glaxo, Syntex, Abbott Laboratories, and SRI— investigated and published on antiviral activity of carbocyclic nucleosides. [read post]
10 Jun 2014, 7:29 am
AndroGel Testosterone Therapy Lawsuits Consolidated The Judicial Panel on Multidistrict Litigation (JPML) issued an order on June 6th to consolidate testosterone therapy injury lawsuits involving Abbott Laboratories and Abbvie, Inc testosterone gels. [read post]
6 Jun 2014, 1:18 pm
Lyon claims that AbbVie, Inc. and Abbott Laboratories withheld important information from patients and doctors about the risk of heart attacks and other blood clot injuries from Androgel use. [read post]
2 Jun 2014, 7:48 am
See, e.g., Abbott Labs. v. [read post]
29 May 2014, 5:00 am
Abbott Labs, Inc., 444 F.3d 383, 387-88 (5th Cir. 2006), and Melder v. [read post]
2 May 2014, 10:23 am
Despite Auxilium Pharmaceuticals’ opposition, a joint response filed on behalf of other testosterone drug manufactures such as Abb Vie, Inc., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
22 Apr 2014, 7:41 am
Procedural HistoryThe New Drug Application (NDA) for the Tarka® product was approved by the Food and Drug Administration in 1996 and acquired by Abbott Laboratories in 2001. [read post]
18 Apr 2014, 9:23 am
Motion Filed to Consolidate AndroGel Testosterone Therapy Lawsuits On March 28th, plaintiffs filed a motion to consolidate all lawsuits against AndroGel, manufactured by AbbVie Inc and Abbott Laboratories, into one multidistrict litigation (MDL). [read post]
1 Apr 2014, 1:44 pm
From this March 29, 2014 article, "Plaintiffs File Motion to Consolidate All Federal Lawsuits Linking AndroGel Testosterone Therapy to Heart Attacks, Strokes" (subscription required for full article), published by HarrisMartin: Plaintiffs in more than a dozen federal lawsuits accusing Abbott Laboratories and AbbVie Inc. of concealing cardiovascular risks associated with the testosterone replacement therapy AndroGel have filed a petition to have all similar cases around the… [read post]
24 Mar 2014, 10:39 am
Plaintiffs Lawsuit Allegations The plaintiffs allege that AbbVie and their parent company Abbott Laboratories knew or should have known about the potential AndroGel heart attack side effects, but withheld important information from patients and doctors. [read post]
20 Mar 2014, 5:34 pm
” Abbott Labs. v. [read post]
17 Mar 2014, 7:20 pm
(now known as Abbott Diabetes Care, Inc.) and Abbott Laboratories (collectively, Abbott).Therasense at *2. [read post]
11 Mar 2014, 6:58 am
by Vall d’Hebron Research Institute (VHIR) A lawsuit was filed last month against Abbott Laboratories and AbbVie, Inc., which manufacture AndroGel, which claims that the heart risks associated with the treatment have been downplayed. [read post]
1 Mar 2014, 6:22 am
. :: Case No. 1:14-cv-879AbbVie Inc., and :Abbott Laboratories, Inc., ::Defendants. [read post]
25 Feb 2014, 10:41 pm
AndroGel was heavily promoted by Abbott Laboratories and AbbVie Inc., with the companies selling the product through testimony from retired professional athletes. [read post]
21 Feb 2014, 8:53 am
Mylan, Inc., 911 F. [read post]
